HuGE Literature Finder
|
||
Records 1-43
|
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern.
Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
|
[Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
|
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.
Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
|
TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes.
Blood cells, molecules & diseases 2019 Feb 74 44-50. Hu Jinjun, Xu Jing, Tian Tingting, Xie Juan, Fan Lifang, Zhu Guiyang, Xia Ting, Chen Xi, Tan Yanhong, Chen Xiuhua, Ren Fanggang, Zhang Yaofang, Wang Hongwei, Xu Zhifa |
|
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts.
Leukemia research 2018 Aug 71 60-62. Mangaonkar Abhishek A, Gangat Naseema, Al-Kali Aref, Elliott Michelle A, Begna Kebede H, Hanson Curtis A, Ketterling Rhett P, Wolanskyj-Spinner Alexandra P, Hogan William J, Litzow Mark R, Patnaik Mrinal |
|
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
Blood cancer journal 2018 Apr 8 (4): 39. Hou Hsin-An, Tsai Cheng-Hong, Lin Chien-Chin, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Tseng Mei-Hsuan, Peng Yen-Ling, Liu Ming-Chih, Liu Chia-Wen, Liao Xiu-Wen, Lin Liang-In, Yao Ming, Tang Jih-Luh, Tien Hwei-Fa |
|
ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics.
Leukemia & lymphoma 2018 Feb 1-8. Kakosaiou Katerina, Panitsas Fotios, Daraki Aggeliki, Pagoni Maria, Apostolou Paraskevi, Ioannidou Agapi, Vlachadami Ioanna, Marinakis Theodoros, Giatra Chara, Vasilatou Diamantina, Sambani Constantina, Pappa Vassiliki, Manola Kalliopi |
|
Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model.
American journal of hematology 2018 Feb . Gangat Naseema, Mudireddy Mythri, Lasho Terra L, Finke Christy M, Nicolosi Maura, Szuber Natasha, Patnaik Mrinal M, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.
American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
|
Clinical significance of somatic mutation in unexplained blood cytopenia.
Blood 2017 Apr . Malcovati Luca, Gallì Anna, Travaglino Erica, Ambaglio Ilaria, Rizzo Ettore, Molteni Elisabetta, Elena Chiara, Ferretti Virginia Valeria, Catricalà Silvia, Bono Elisa, Todisco Gabriele, Bianchessi Antonio, Rumi Elisa, Zibellini Silvia, Pietra Daniela, Boveri Emanuela, Camaschella Clara, Toniolo Daniela, Papaemmanuil Elli, Ogawa Seishi, Cazzola Mar |
|
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
|
ASXL1 mutations are frequent in de novo AML with trisomy 8 and confer an unfavorable prognosis.
Leukemia & lymphoma 2016 Oct 1-3. Zong Xiangping, Yao Hong, Wen Lijun, Ma Liang, Wang Qinrong, Yang Zhiluo, Zhang Tongtong, Chen Suning, Depei |
|
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep . Della Porta Matteo G, Gallì Anna, Bacigalupo Andrea, Zibellini Silvia, Bernardi Massimo, Rizzo Ettore, Allione Bernardino, van Lint Maria Teresa, Pioltelli Pietro, Marenco Paola, Bosi Alberto, Voso Maria Teresa, Sica Simona, Cuzzola Mariella, Angelucci Emanuele, Rossi Marianna, Ubezio Marta, Malovini Alberto, Limongelli Ivan, Ferretti Virginia V, Spinelli Orietta, Tresoldi Cristina, Pozzi Sarah, Luchetti Silvia, Pezzetti Laura, Catricalà Silvia, Milanesi Chiara, Riva Alberto, Bruno Benedetto, Ciceri Fabio, Bonifazi Francesca, Bellazzi Riccardo, Papaemmanuil Elli, Santoro Armando, Alessandrino Emilio P, Rambaldi Alessandro, Cazzola Mar |
|
Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2.
Experimental hematology 2016 Jul . Buscarlet Manuel, Tessier Alain, Provost Sylvie, Mollica Luigina, Busque Lambe |
|
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations.
Oncotarget 2016 Jun . Shin Sang-Yong, Lee Seung-Tae, Kim Hee-Jin, Cho Eun Hae, Kim Jong-Won, Park Silvia, Jung Chul Won, Kim Sun-H |
|
Clonal hematopoiesis in acquired aplastic anemia.
Blood 2016 Apr . Ogawa Seis |
|
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
American journal of hematology 2016 Feb . Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
|
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.
Blood 2015 Dec . Chesnais Virginie, Renneville Aline, Toma Andrea, Lambert Jérôme, Passet Marie, Dumont Florent, Chevret Sylvie, Lejeune Julie, Raimbault Anna, Stamatoullas Aspasia, Rose Christian, Beyne-Rauzy Odile, Delaunay Jacques, Solary Eric, Fenaux Pierre, Dreyfus François, Preudhomme Claude, Kosmider Olivier, Fontenay Michae |
|
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.
Nature communications 2015 6 5901. Gerstung Moritz, Pellagatti Andrea, Malcovati Luca, Giagounidis Aristoteles, Porta Matteo G Della, Jädersten Martin, Dolatshad Hamid, Verma Amit, Cross Nicholas C P, Vyas Paresh, Killick Sally, Hellström-Lindberg Eva, Cazzola Mario, Papaemmanuil Elli, Campbell Peter J, Boultwood Jacqueli |
|
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
Blood 2014 Oct 124 (16): 2596-606. Pidala Joseph, Lee Stephanie J, Ahn Kwang Woo, Spellman Stephen, Wang Hai-Lin, Aljurf Mahmoud, Askar Medhat, Dehn Jason, Fernandez Viña Marcelo, Gratwohl Alois, Gupta Vikas, Hanna Rabi, Horowitz Mary M, Hurley Carolyn K, Inamoto Yoshihiro, Kassim Adetola A, Nishihori Taiga, Mueller Carlheinz, Oudshoorn Machteld, Petersdorf Effie W, Prasad Vinod, Robinson James, Saber Wael, Schultz Kirk R, Shaw Bronwen, Storek Jan, Wood William A, Woolfrey Ann E, Anasetti Claud |
|
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
Blood 2014 Oct 124 (17): 2705-12. Bejar Rafael, Lord Allegra, Stevenson Kristen, Bar-Natan Michal, Pérez-Ladaga Albert, Zaneveld Jacques, Wang Hui, Caughey Bennett, Stojanov Petar, Getz Gad, Garcia-Manero Guillermo, Kantarjian Hagop, Chen Rui, Stone Richard M, Neuberg Donna, Steensma David P, Ebert Benjamin |
|
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Sep 32 (25): 2691-8. Bejar Rafael, Stevenson Kristen E, Caughey Bennett, Lindsley R Coleman, Mar Brenton G, Stojanov Petar, Getz Gad, Steensma David P, Ritz Jerome, Soiffer Robert, Antin Joseph H, Alyea Edwin, Armand Philippe, Ho Vincent, Koreth John, Neuberg Donna, Cutler Corey S, Ebert Benjamin |
|
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.
American journal of hematology 2014 Aug 89 (8): E109-15. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Wu Shang-Ju, Liu Chieh-Yu, Chen Chien-Yuan, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Hsu Szu-Chun, Ko Bor-Sheng, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
|
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.
American journal of hematology 2014 Feb 89 (2): 181-6. Hou Hsin-An, Kuo Yuan-Yeh, Tang Jih-Luh, Chou Wen-Chien, Yao Ming, Lai Yan-Jun, Lin Chien-Chin, Chen Chien-Yuan, Liu Chieh-Yu, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
|
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.
American journal of hematology 2014 Feb 89 (2): 137-44. Lin Chien-Chin, Hou Hsin-An, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Chen Chien-Yuan, Lai Yan-Jun, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
|
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
Leukemia 2014 Feb 28 (2): 241-7. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler H P, Klein H-U, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa |
|
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.
Leukemia 2014 Jan 28 (1): 78-87. Traina F, Visconte V, Elson P, Tabarroki A, Jankowska A M, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe C L, Sekeres M A, Advani A S, Kalaycio M, Copelan E A, Saunthararajah Y, Olalla Saad S T, Maciejewski J P, Tiu R |
|
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Haematologica 2013 Dec 98 (12): 1856-64. Fernandez-Mercado Marta, Burns Adam, Pellagatti Andrea, Giagounidis Aristoteles, Germing Ulrich, Agirre Xabier, Prosper Felipe, Aul Carlo, Killick Sally, Wainscoat James S, Schuh Anna, Boultwood Jacqueli |
|
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Blood 2013 Oct 122 (18): 3169-77. Damm Frederik, Chesnais Virginie, Nagata Yasunobu, Yoshida Kenichi, Scourzic Laurianne, Okuno Yusuke, Itzykson Raphael, Sanada Masashi, Shiraishi Yuichi, Gelsi-Boyer Véronique, Renneville Aline, Miyano Satoru, Mori Hiraku, Shih Lee-Yung, Park Sophie, Dreyfus François, Guerci-Bresler Agnes, Solary Eric, Rose Christian, Cheze Stéphane, Prébet Thomas, Vey Norbert, Legentil Marion, Duffourd Yannis, de Botton Stéphane, Preudhomme Claude, Birnbaum Daniel, Bernard Olivier A, Ogawa Seishi, Fontenay Michaela, Kosmider Olivi |
|
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
|
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes.
Leukemia research 2013 Mar 37 (3): 305-11. Wang Jieyu, Ai Xiaofei, Gale Robert Peter, Xu Zefeng, Qin Tiejun, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Zhang Yue, Xiao Zhiji |
|
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
Leukemia 2013 Jan 27 (1): 82-91. Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, Kohlmann A, Illig T, Klopp N, Wichmann H-E, Kreuzer K-A, Schmid C, Staib P, Peceny R, Schmitz N, Kern W, Haferlach C, Haferlach |
|
Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2 and DNMT3A.
Blood 2013 Jan . Liang DC, Liu HC, Yang CP, Jaing TH, Hung IJ, Yeh TC, Chen SH, Hou JY, Huang YJ, Shih YS, Huang YH, Lin TH, Shih LY |
|
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
|
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (27): 3376-82. Bejar Rafael, Stevenson Kristen E, Caughey Bennett A, Abdel-Wahab Omar, Steensma David P, Galili Naomi, Raza Azra, Kantarjian Hagop, Levine Ross L, Neuberg Donna, Garcia-Manero Guillermo, Ebert Benjamin |
|
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
|
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood 2011 Dec 118 (26): 6920-9. Metzeler Klaus H, Becker Heiko, Maharry Kati, Radmacher Michael D, Kohlschmidt Jessica, Mrózek Krzysztof, Nicolet Deedra, Whitman Susan P, Wu Yue-Zhong, Schwind Sebastian, Powell Bayard L, Carter Thomas H, Wetzler Meir, Moore Joseph O, Kolitz Jonathan E, Baer Maria R, Carroll Andrew J, Larson Richard A, Caligiuri Michael A, Marcucci Guido, Bloomfield Clara |
|
Clinical effect of point mutations in myelodysplastic syndromes.
The New England journal of medicine 2011 Jun 364 (26): 2496-506. Bejar Rafael, Stevenson Kristen, Abdel-Wahab Omar, Galili Naomi, Nilsson Björn, Garcia-Manero Guillermo, Kantarjian Hagop, Raza Azra, Levine Ross L, Neuberg Donna, Ebert Benjamin |
|
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Jun 29 (18): 2499-506. Thol Felicitas, Friesen Inna, Damm Frederik, Yun Haiyang, Weissinger Eva M, Krauter Jürgen, Wagner Katharina, Chaturvedi Anuhar, Sharma Amit, Wichmann Martin, Göhring Gudrun, Schumann Christiane, Bug Gesine, Ottmann Oliver, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Heuser Michael, Ganser Arno |
|
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
|
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Leukemia 2010 May 24 (5): 1062-5. Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz M J, Larrayoz M J, Garcia-Delgado M, Giagounidis A, Malcovati L, Della Porta M G, Jädersten M, Killick S, Hellström-Lindberg E, Cazzola M, Wainscoat J |
|
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.
BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
|
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
British journal of haematology 2009 Jun 145 (6): 788-800. Gelsi-Boyer Véronique, Trouplin Virginie, Adélaïde José, Bonansea Julien, Cervera Nathalie, Carbuccia Nadine, Lagarde Arnaud, Prebet Thomas, Nezri Meyer, Sainty Danielle, Olschwang Sylviane, Xerri Luc, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 31, 2019
- Content source: